• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在乙型肝炎 Delta 病毒(HDV)感染的体内模型中:人源化 NTCP 就足够了吗?

In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?

机构信息

Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems Site, Germany.

出版信息

Viruses. 2021 Mar 31;13(4):588. doi: 10.3390/v13040588.

DOI:10.3390/v13040588
PMID:33807170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065588/
Abstract

The discovery of sodium taurocholate co-transporting polypeptide (NTCP) as a hepatitis B (HBV) and delta virus (HDV) entry receptor has encouraged the development of new animal models of infection. This review provides an overview of the different in vivo models that are currently available to study HDV either in the absence or presence of HBV. By presenting new advances and remaining drawbacks, we will discuss human host factors which, in addition to NTCP, need to be investigated or identified to enable a persistent HDV infection in murine hepatocytes. Detailed knowledge on species-specific factors involved in HDV persistence also shall contribute to the development of therapeutic strategies.

摘要

牛磺胆酸钠共转运多肽(NTCP)作为乙型肝炎(HBV)和丁型肝炎(HDV)病毒进入受体的发现,鼓励了新的感染动物模型的发展。本综述概述了目前可用于研究无 HBV 或有 HBV 情况下 HDV 的不同体内模型。通过介绍新的进展和仍然存在的缺陷,我们将讨论除 NTCP 外,还需要研究或鉴定的人类宿主因素,以使鼠肝细胞能够持续感染 HDV。对涉及 HDV 持续感染的种特异性因素的详细了解也将有助于治疗策略的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/8065588/8541f04768f9/viruses-13-00588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/8065588/8541f04768f9/viruses-13-00588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/8065588/8541f04768f9/viruses-13-00588-g001.jpg

相似文献

1
In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?在乙型肝炎 Delta 病毒(HDV)感染的体内模型中:人源化 NTCP 就足够了吗?
Viruses. 2021 Mar 31;13(4):588. doi: 10.3390/v13040588.
2
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.乙型肝炎和丁型肝炎病毒利用牛磺胆酸钠共转运多肽进行种属特异性进入肝细胞。
Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.
3
Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.乙型肝炎和丁型肝炎病毒的病毒进入以及胆汁盐转运共用牛磺胆酸钠共转运多肽上的共同分子决定因素。
J Virol. 2014 Mar;88(6):3273-84. doi: 10.1128/JVI.03478-13. Epub 2014 Jan 3.
4
Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.表达人牛磺胆酸钠共转运多肽的小鼠的丁型肝炎病毒感染
PLoS Pathog. 2015 Apr 22;11(4):e1004840. doi: 10.1371/journal.ppat.1004840. eCollection 2015 Apr.
5
Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.牛磺胆酸钠共转运多肽中三个氨基酸的修饰使小鼠在体内易感染丁型肝炎病毒。
J Virol. 2016 Sep 12;90(19):8866-74. doi: 10.1128/JVI.00901-16. Print 2016 Oct 1.
6
Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.牛磺胆酸钠共转运蛋白是乙型肝炎病毒感染猕猴和猪肝细胞的限制宿主因子。
Hepatology. 2017 Sep;66(3):703-716. doi: 10.1002/hep.29112. Epub 2017 Jul 18.
7
Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.乙型肝炎和丁型肝炎病毒进入限制的分子决定因素在小鼠牛磺胆酸钠共转运多肽中。
J Virol. 2013 Jul;87(14):7977-91. doi: 10.1128/JVI.03540-12. Epub 2013 May 15.
8
HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.乙肝病毒生命周期在表达人钠离子-牛磺胆酸共转运多肽(NTCP)的小鼠肝细胞中受到限制。
Cell Mol Immunol. 2014 Mar;11(2):175-83. doi: 10.1038/cmi.2013.66. Epub 2014 Feb 10.
9
Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).初级胆汁酸抑制丁型肝炎病毒(HDV)进入表达牛磺胆酸钠共转运多肽(NTCP)的人肝癌细胞。
PLoS One. 2015 Feb 3;10(2):e0117152. doi: 10.1371/journal.pone.0117152. eCollection 2015.
10
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.环孢素 A 通过非亲环素依赖性干扰 NTCP 受体抑制乙型肝炎和丁型肝炎病毒进入。
J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1.

引用本文的文献

1
Mice Engrafted with Human Liver Cells.移植了人类肝细胞的小鼠。
Semin Liver Dis. 2024 Nov;44(4):405-415. doi: 10.1055/s-0044-1790601. Epub 2024 Sep 12.
2
cell culture models to study hepatitis B and D virus infection.用于研究乙型肝炎和丁型肝炎病毒感染的细胞培养模型。
Front Microbiol. 2023 Apr 5;14:1169770. doi: 10.3389/fmicb.2023.1169770. eCollection 2023.
3
Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment.研究肝脏微环境中T细胞对嗜肝病毒的反应。

本文引用的文献

1
Hepatitis B virus cccDNA is formed through distinct repair processes of each strand.乙型肝炎病毒 cccDNA 通过每条链的不同修复过程形成。
Nat Commun. 2021 Mar 11;12(1):1591. doi: 10.1038/s41467-021-21850-9.
2
Identification of novel avian and mammalian deltaviruses provides new insights into deltavirus evolution.新型禽源和哺乳动物源丁型肝炎病毒的鉴定为丁型肝炎病毒的进化提供了新见解。
Virus Evol. 2021 Feb 12;7(1):veab003. doi: 10.1093/ve/veab003. eCollection 2021 Jan.
3
The changing context of hepatitis D.丁型肝炎不断变化的背景
Vaccines (Basel). 2023 Mar 17;11(3):681. doi: 10.3390/vaccines11030681.
4
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.Bulevirtide 治疗乙型肝炎 delta 病毒:药物发现、临床开发和治疗地位。
Drug Des Devel Ther. 2023 Jan 21;17:155-166. doi: 10.2147/DDDT.S379964. eCollection 2023.
5
Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus.乙型肝炎和丁型肝炎病毒:免疫重点的综合更新。
Int J Mol Sci. 2022 Dec 15;23(24):15973. doi: 10.3390/ijms232415973.
6
Virome of Three Termite Species from Southern Vietnam.越南南部三种白蚁的病毒组。
Viruses. 2022 Apr 21;14(5):860. doi: 10.3390/v14050860.
J Hepatol. 2021 May;74(5):1200-1211. doi: 10.1016/j.jhep.2021.01.014. Epub 2021 Jan 20.
4
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study.残余低HDV病毒血症与基于聚乙二醇干扰素α的丁型肝炎抗病毒治疗后HDV RNA复发相关:HIDIT-II研究结果
Liver Int. 2021 Feb;41(2):295-299. doi: 10.1111/liv.14740. Epub 2020 Dec 5.
5
Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.乙型肝炎病毒感染的肝细胞中,δ 型肝炎病毒作为一种免疫原性佐剂。
Cell Rep Med. 2020 Jul 21;1(4):100060. doi: 10.1016/j.xcrm.2020.100060.
6
Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.在对感染乙型肝炎病毒和丁型肝炎病毒的黑猩猩进行的纵向研究中,不同的细胞因子谱与疾病严重程度和结果相关。
mBio. 2020 Nov 17;11(6):e02580-20. doi: 10.1128/mBio.02580-20.
7
New Insights on Molecular Mechanism of Hepatitis B Virus Covalently Closed Circular DNA Formation.乙型肝炎病毒共价闭合环状 DNA 形成的分子机制新见解。
Cells. 2020 Nov 6;9(11):2430. doi: 10.3390/cells9112430.
8
Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.小鼠肝细胞不支持丁型肝炎病毒单一感染在体内持续存在。
Liver Int. 2021 Feb;41(2):410-419. doi: 10.1111/liv.14677. Epub 2020 Oct 15.
9
Bulevirtide: First Approval.布乐韦替尼:美国首次批准
Drugs. 2020 Oct;80(15):1601-1605. doi: 10.1007/s40265-020-01400-1.
10
Hepatitis delta virus propagation enabled by hepatitis C virus-Scientifically intriguing, but is it relevant to clinical practice?乙型肝炎 delta 病毒的复制由丙型肝炎病毒介导——这一科学发现引人入胜,但它与临床实践相关吗?
J Viral Hepat. 2021 Jan;28(1):213-216. doi: 10.1111/jvh.13385. Epub 2020 Oct 4.